Expert wants anti-cancer drug subsidised | South China Morning Post
  • Wed
  • Mar 4, 2015
  • Updated: 10:48am

Expert wants anti-cancer drug subsidised

PUBLISHED : Wednesday, 14 May, 2008, 12:00am
UPDATED : Wednesday, 14 May, 2008, 12:00am

A University of Hong Kong cancer expert wants a newly registered anti-breast cancer drug put on the Hospital Authority's formulary. Daniel Chua Tsin-tien, associate professor of HKU's clinical oncology department, said that tests using the drug, lapatinib, combined with capecitabine, showed an 88 per cent chance of patients with last-stage HER2 breast cancer controlling the disease. There was a 35 per cent chance tumours would shrink in size by more than half.

Share

Related topics

For unlimited access to:

SCMP.com SCMP Tablet Edition SCMP Mobile Edition 10-year news archive
 
 

 

 
 
 
 
 

Login

SCMP.com Account

or